Papaverine and prostaglandin E1 gel applications for impotence

H. S. Chiang, Y. H. Kao, M. T. Sheu

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

The transdermal permeability of papaverine and prostaglandin E1 (PGE1) could be determined in vitro. A chemical scheme of passive delivery or with enhancer, as well as a physical iontophoretic transdermal delivery system were designed in the laboratory. Clinically, up to 20% papaverine base gel and 500 μg PGE1 were applied onto the genital area without any side effect. Only vascular response could be detected by ultrasound. However, immediate erection could not be obtained at the present dosage. Further research on the combination of skin absorption enhancers, the different chemical derivatives of PGE1 or a different administration route is warranted.

Original languageEnglish
Pages (from-to)767-769
Number of pages3
JournalAnnals of the Academy of Medicine Singapore
Volume24
Issue number5
Publication statusPublished - 1995

Fingerprint

Papaverine
Alprostadil
Erectile Dysfunction
Gels
Skin Absorption
Blood Vessels
Permeability
Research

Keywords

  • erectile dysfunction
  • intracavernosal vasodilating agent
  • iontophoresis
  • male sexual therapy
  • transdermal delivery system

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Papaverine and prostaglandin E1 gel applications for impotence. / Chiang, H. S.; Kao, Y. H.; Sheu, M. T.

In: Annals of the Academy of Medicine Singapore, Vol. 24, No. 5, 1995, p. 767-769.

Research output: Contribution to journalArticle

@article{e715ceb9d3b2438f8cdb3c3c84ebb793,
title = "Papaverine and prostaglandin E1 gel applications for impotence",
abstract = "The transdermal permeability of papaverine and prostaglandin E1 (PGE1) could be determined in vitro. A chemical scheme of passive delivery or with enhancer, as well as a physical iontophoretic transdermal delivery system were designed in the laboratory. Clinically, up to 20{\%} papaverine base gel and 500 μg PGE1 were applied onto the genital area without any side effect. Only vascular response could be detected by ultrasound. However, immediate erection could not be obtained at the present dosage. Further research on the combination of skin absorption enhancers, the different chemical derivatives of PGE1 or a different administration route is warranted.",
keywords = "erectile dysfunction, intracavernosal vasodilating agent, iontophoresis, male sexual therapy, transdermal delivery system",
author = "Chiang, {H. S.} and Kao, {Y. H.} and Sheu, {M. T.}",
year = "1995",
language = "English",
volume = "24",
pages = "767--769",
journal = "Annals of the Academy of Medicine, Singapore",
issn = "0304-4602",
publisher = "Academy of Medicine Singapore",
number = "5",

}

TY - JOUR

T1 - Papaverine and prostaglandin E1 gel applications for impotence

AU - Chiang, H. S.

AU - Kao, Y. H.

AU - Sheu, M. T.

PY - 1995

Y1 - 1995

N2 - The transdermal permeability of papaverine and prostaglandin E1 (PGE1) could be determined in vitro. A chemical scheme of passive delivery or with enhancer, as well as a physical iontophoretic transdermal delivery system were designed in the laboratory. Clinically, up to 20% papaverine base gel and 500 μg PGE1 were applied onto the genital area without any side effect. Only vascular response could be detected by ultrasound. However, immediate erection could not be obtained at the present dosage. Further research on the combination of skin absorption enhancers, the different chemical derivatives of PGE1 or a different administration route is warranted.

AB - The transdermal permeability of papaverine and prostaglandin E1 (PGE1) could be determined in vitro. A chemical scheme of passive delivery or with enhancer, as well as a physical iontophoretic transdermal delivery system were designed in the laboratory. Clinically, up to 20% papaverine base gel and 500 μg PGE1 were applied onto the genital area without any side effect. Only vascular response could be detected by ultrasound. However, immediate erection could not be obtained at the present dosage. Further research on the combination of skin absorption enhancers, the different chemical derivatives of PGE1 or a different administration route is warranted.

KW - erectile dysfunction

KW - intracavernosal vasodilating agent

KW - iontophoresis

KW - male sexual therapy

KW - transdermal delivery system

UR - http://www.scopus.com/inward/record.url?scp=0028971002&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028971002&partnerID=8YFLogxK

M3 - Article

C2 - 8579329

AN - SCOPUS:0028971002

VL - 24

SP - 767

EP - 769

JO - Annals of the Academy of Medicine, Singapore

JF - Annals of the Academy of Medicine, Singapore

SN - 0304-4602

IS - 5

ER -